Cite
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
MLA
Natriuretic Peptides Studies Collaboration, et al. Natriuretic Peptides and Integrated Risk Assessment for Cardiovascular Disease: An Individual-Participant-Data Meta-Analysis. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3891..a11ad7953e5bad8327e6843181bf0bce&authtype=sso&custid=ns315887.
APA
Natriuretic Peptides Studies Collaboration, Willeit P, Kaptoge S, Welsh P, Butterworth AS, Chowdhury R, Spackman SA, Pennells L, Gao P, Burgess S, Freitag DF, Sweeting M, Wood AM, Cook NR, Judd S, Trompet S, Nambi V, Olsen MH, Everett BM, & Kee F et al. (2016). Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.
Chicago
Natriuretic Peptides Studies Collaboration, Willeit P, Kaptoge S, Welsh P, Butterworth AS, Chowdhury R, Spackman SA, et al. 2016. “Natriuretic Peptides and Integrated Risk Assessment for Cardiovascular Disease: An Individual-Participant-Data Meta-Analysis,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3891..a11ad7953e5bad8327e6843181bf0bce&authtype=sso&custid=ns315887.